Ozempic’s Shadow Is Getting Longer – and Smarter Investors Are Watching the Supply Chain
GLP-1 demand is reshaping pharma, medtech, and even consumer staples in 2026
May 30, 2026
MELI Just Posted 49% Revenue Growth – and the Market Punished It Anyway
MercadoLibre is trading at a multi-year low while compounding faster than almost any business its size on earth.